Skip to main content

HeartFlow

HeartFlow Inc is an American multinational medical technology and digital health enterprise specializing in the research, development, and provision of advanced cardiovascular diagnostic software and non-invasive artificial intelligence (AI) imaging analysis solutions, prominently featuring the HeartFlow Analysis platform which translates standard coronary computed tomography angiography (CTA) scans into three-dimensional color-coded models displaying precise fractional flow reserve (FFR-CT) values to evaluate coronary artery disease without invasive procedures. The company operates advanced medical software engineering and cloud-based analysis facilities. Its core business operations encompass medical software development, AI cardiovascular analytics, cloud processing of clinical imaging, and healthcare regulatory compliance. Revenue is derived primarily from software-as-a-service (SaaS) per-analysis diagnostic fees and hospital licensing agreements. HeartFlow holds a leading global market position in non-invasive cardiovascular AI diagnostics. The company is headquartered in Mountain View, California, United States, operating as a premier medical technology enterprise.

4 of the funds FundTelligence covers report a position in HeartFlow.

Legal name
HeartFlow Inc
Sector
Health Care
Country
United States
Funds holding it
4
Exposure themes
Artificial Intelligence, Diagnostics & Imaging, Healthcare

Funds holding HeartFlow

Loading...